Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$853K Sell
30,379
-80
-0.3% -$2.13K 0.33% 96
2025
Q4
$758K Buy
30,459
+551
+2% +$13.9K 0.31% 99
2025
Q3
$762K Hold
29,908
0.32% 95
2025
Q2
$725K Buy
+29,908
New +$697K 0.34% 91
2024
Q2
Sell
-10,813
Closed -$300K 313
2024
Q1
$300K Hold
10,813
0.18% 118
2023
Q4
$311K Hold
10,813
0.2% 112
2023
Q3
$359K Hold
10,813
0.26% 110
2023
Q2
$397K Sell
10,813
-1,000
-8% -$38.9K 0.26% 112
2023
Q1
$482K Hold
11,813
0.34% 104
2022
Q4
$605K Buy
11,813
+1,397
+13% +$67K 0.43% 89
2022
Q3
$456K Hold
10,416
0.36% 100
2022
Q2
$546K Hold
10,416
0.4% 95
2022
Q1
$539K Hold
10,416
0.31% 109
2021
Q4
$615K Hold
10,416
0.32% 107
2021
Q3
$448K Hold
10,416
0.26% 118
2021
Q2
$408K Hold
10,416
0.23% 121
2021
Q1
$377K Buy
10,416
+725
+7% +$25.7K 0.24% 114
2020
Q4
$357K Buy
9,691
+3,614
+59% +$133K 0.26% 111
2020
Q3
$212K Buy
6,077
+1,728
+40% +$60.6K 0.19% 120
2020
Q2
$135K Sell
4,349
-1,962
-31% -$66.7K 0.15% 132
2020
Q1
$195K Buy
6,311
+585
+10% +$19.9K 0.25% 115
2019
Q4
$213K Buy
5,726
+1,106
+24% +$39.4K 0.18% 133
2019
Q3
$157K Hold
4,620
0.15% 142
2019
Q2
$190K Hold
4,620
0.18% 131
2019
Q1
$186K Hold
4,620
0.19% 128
2018
Q4
$191K Buy
+4,620
New +$192K 0.24% 119

Other funds holding PFE

Legacy Bridge's PFE Position: Q1 2026 in Review

Legacy Bridge reduced its Pfizer (PFE) stake by 0.26% in Q1 2026, selling an estimated $2.13K and leaving 30,379 shares worth $853K. The position accounts for 0.33% of the portfolio, ranked #96.

Legacy Bridge first reported a position in PFE in Q4 2018 and has held it in 26 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Legacy Bridge held 30,379 shares of Pfizer worth $853K as of Q1 2026.
  • Legacy Bridge sold 80 Pfizer shares in Q1 2026, an estimated $2.13K.
  • Pfizer made up 0.33% of Legacy Bridge's portfolio in Q1 2026, its #96 holding.
  • Legacy Bridge first reported a position in Pfizer in Q4 2018 and has held it in 26 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.